March 2017 Features
Announcements
Contact Us
|
Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies
Applications Due: June 1, 2017
Expiration Date: June 2, 2017
Supplement Opportunity to Support Population-Based Research Studies of Rare Cancers
Applications Due: June 1, 2017
Expiration Date: June 2, 2017
Supplements for Validating the Use of Automated Sources of Residential Histories in Cancer Epidemiology Cohorts
Applications Due: June 1, 2017
Expiration Date: June 2, 2017
Research Answers to NCI's Provocative Questions Applications Due: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018
Expiration Date: October 31, 2018
RFA-CA-17-019 (R01)
RFA-CA-17-021 (P01)
Revision Applications to NCI-Supported Awards to Include Research on the NCI's Provocative Questions
Applications Due: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018
Expiration Date: October 31, 2018
PAR-17-151 (R01)
Mechanisms of Disparities in Chronic Liver Diseases and Cancer
Applications Due: May 22, 2017; April 4, 2018; April 4, 2019
Expiration Date: April 5, 2019
Notice of Intent to Publish a Funding Opportunity Announcement for New Epidemiology Cohorts in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)
Notice of Intent to Publish a Funding Opportunity Announcement for Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)
|
Update and Clarification: NIH Continuous Submission Policy
NOT-OD-17-050 Reporting Preprints and Other Interim Research Products
NOT-OD-17-049 Interim Guidance on Salary Limitation for Grants and Cooperative Agreements
NOT-CA-17-042 NCI Will Support Training in Patient-Oriented Research Through K08 Awards and Increase K08 Salary and Research Support
NOT-OD-17-048 NIH Operates Under a Continuing Resolution
|
Comments due by April 16, 2017
Comments due by April 30, 2017
|
April 6, 2017
Bethesda, MD
Infectious Agents and Cancer Epidemiology Research Webinar Series
April 11, 2017
May 3-5, 2017
New Orleans, LA
May 4-5, 2017
Memphis, TN
May 16-17, 2017
Bethesda, MD
May 31-June 1, 2017 Rockville, MD
International Conference on Ambulatory Monitoring of Physical Activity and Movement June 21-23, 2017 Bethesda, MD |
The Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS) funds research in human populations to understand the causes of cancer and related outcomes.
The Program fosters interdisciplinary collaborations, as well as the development and use of resources and technologies to advance cancer research and translation of this research, which serve as the basis for clinical and public health interventions. |
|
|
The 2017 AACR Annual Meeting: 16 Sessions for Epidemiologists
|
The 108th
Annual Meeting of the American Association for Cancer Research (AACR) will take place from April 1-5, 2017 in Washington, DC. To help those planning to attend make the most out of their time at this year's meeting, the Epidemiology and Genomics Research Program (EGRP) has assembled a list of selected sessions presented by National Cancer Institute (NCI) staff, grantees, and collaborators that highlight important resources and topics in cancer epidemiology and genomics, funding opportunities, and grantsmanship issues.
Monday, April 3:
- 2:00 p.m. - 3:00 p.m., NIH-Supported International COnsortium of METabolomics Studies (COMETS) (Marquis Ballroom Salons 3-4)
- 2:45 p.m. - 3:15 p.m., Meet-the-Expert Session, Emerging Challenges in Survivorship Science (NCI Booth #1407, Exhibit Hall A)
- This session features Julia Rowland, Ph.D., of NCI's Division of Cancer Control and Population Sciences (DCCPS).
- 4:15 p.m. - 6:15 p.m., NCI's Center for Cancer Genomics and Cloud Pilots Initiatives: Using Large-Scale Data to Advance Precision Oncology (Marquis Ballroom Salons 3-4)
- 5:30 p.m. - 6:15 p.m., Molecular Epidemiology Working Group Networking Session with Early-Career Researchers, Part 2: Meet the MEG Experts (Treasury Room),
- 6:30 p.m. - 8:00 p.m., Molecular Epidemiology Working Group (MEG) Town Hall Meeting and Reception (Independence Ballroom E-H)
Tuesday, April 4:
- 7:00 a.m. - 8:00 a.m., Utilizing "Normal" Genomic Data from the GTEx Project in Cancer Research (Marquis Ballroom Salons 3-4)
- 9:30 a.m. - 10:00 a.m., Meet-the-Expert Session, Opportunities for Health Behavior Research: Energy Balance, Cancer Prevention, and Control (NCI Booth #1407, Exhibit Hall A)
- 10:15 a.m. - 10:45 p.m., Meet-the-Expert Session, Epidemiologic Research in Understudied Populations (NCI Booth #1407, Exhibit Hall A)
- 2:45 p.m. - 4:45 p.m., NCI Cross-Disciplinary Programs Supporting Integrated Cancer Research (Marquis Ballroom Salons 3-4)
- This session will feature technologies and innovative approaches from NCI's Innovative Molecular Analysis Technologies and Informatics Technologies for Cancer Research programs.
- 5:00 p.m. - 6:30 p.m., NCI's Provocative Questions Initiative: Objectives, Outcomes, Lessons Learned (Marquis Ballroom Salons 3-4)
Wednesday, April 5:
- 9:30 a.m. - 10:00 a.m., Meet-the-Expert Session, Cancer Epidemiology Cohorts (NCI Booth #1407, Exhibit Hall A)
- 10:15 a.m. - 10:45 a.m., Meet-the Expert Session, Resources to Develop, Implement, and Evaluate Cancer Screening Programs (NCI Booth #1407, Exhibit Hall A)
- 10:15 a.m. - 11:45 a.m., NCI Funding Opportunities to Increase Diversity in Cancer Research (Room 140, Level 1)
- This session will feature staff from NCI's Center to Reduce Cancer Health Disparities.
If you are attending AACR this year, don't forget to add these sessions to your
personal meeting itinerary
before you go. Visit the NCI website to
sign up for emails on NCI participation at AACR
and other conferences.
|
NCI Publishes New Provocative Questions Initiative Funding Opportunity Announcements
|
The NCI's Provocative Questions (PQ) Initiative is intended to stimulate specific areas of cancer research that are understudied, neglected, paradoxical, and/or have been difficult to address in the past.
NCI has identified 12 PQs in the Funding Opportunity Announcements (FOAs) published in March 2017. Investigators are encouraged to submit a letter of intent 30 days prior to the application due date to determine whether their proposed research idea is responsive to one of the 12 PQs.
The 2017 application receipt dates are June 28 and October 30.
The following PQs may be of particular interest to population science researchers:
- PQ-1: What molecular mechanisms influence disease penetrance in individuals who inherit a cancer susceptibility gene?
- PQ-2: How do variations in immune function caused by comorbidities or observed among different populations affect response to cancer therapy?
- PQ-3: Do genetic interactions between germline variations and somatic mutations contribute to differences in tumor evolution or response to therapy?
- PQ-6: How do circadian processes affect tumor development, progression, and response to therapy?
- PQ-10: How do microbiota affect the response to cancer therapies?
- PQ-11: Through what mechanisms do diet and nutritional interventions affect the response to cancer treatment?
- PQ-12: What are the molecular and/or cellular mechanisms that underlie the development of cancer therapy-induced severe adverse sequelae?
The other questions can be viewed on NCI's
PQ Initiative website.
There are also four additional FOAs intended for revision applications (formerly referred to as competing supplements) to add PQ-relevant research to eligible NIH and/or NCI-supported parent awards for R01, U01, P01, and P50 awards.
To be considered eligible to respond to one of the PQ FOAs for revision applications, investigators must have at least two years remaining in their original award period or no-cost extension. No more than two years of support can be requested and the budget cap is $150,000 direct costs per year.
The revision applications will be reviewed by the same Special Emphasis Panels (SEPs) that review the Provocative Questions initiative R01 and R21 applications.
Learn more about the PQ FOAs through the
NIH Guide for Grants and Contracts:
|
|